Raised TSH is associated with endothelial dysfunction in Metabolic Syndrome: A case control study

1. AHIRWAR AK., JAIN A., GOSWAMI B., BHATNAGAR MK., BHATACHARJEE J. Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome. Diab Met Syndr: Clin Res Rev. 2014; 8 (3):152-5.10.1016/j.dsx.2014.04.035Search in Google Scholar

2. ALBERTI G., ZIMMET P., SHAW J., GRUNDY SM. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation. 2006 Nov 8:1-23.10.1111/j.1464-5491.2006.01858.xSearch in Google Scholar

3. MOZUMDAR A., LIGUORI G. Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999–2006. Diabetes Care. 2011 Jan 1; 34 (1):216-9.10.2337/dc10-0879Search in Google Scholar

4. PRASAD DS., KABIR Z., DASH AK., DAS BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. Journal of cardiovascular disease research. 2012 Sep 30; 3 (3):204-11.10.4103/0975-3583.98895Search in Google Scholar

5. TZIOMALOS K., ATHYROS VG., KARAGIANNIS A., MIKHAILIDIS DP. Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutrition, Metabolism and Cardiovascular Diseases. 2010 Feb 28; 20 (2):140-6.10.1016/j.numecd.2009.08.006Open DOISearch in Google Scholar

6. HADI HA., CARR CS., SUWAIDI JA. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vascular health and risk management. 2005 Sep; 1 (3):183.Search in Google Scholar

7. NIKNAM N., KHALILI N., KHOSRAVI E., NOURBAKHSH M. Endothelial dysfunction in patients with subclinical hypothyroidism and the effects of treatment with levothyroxine. Advanced biomedical research. 2016; 5.10.4103/2277-9175.178783Search in Google Scholar

8. MATHEW F., GLENDA J., JACK L. Quantification of nitric and nitrate in extracellular fluids. Metho Enzymol 1996; 268:237-46.10.1016/S0076-6879(96)68026-4Search in Google Scholar

9. La Vignera S., Condorelli R., Vicari E., Calogero AE. Endothelial dysfunction and subclinical hypothyroidism: A brief review. J Endocrinol Invest. 2012; 35 (1): 96-103.Search in Google Scholar

10. CABRAL MD., TEIXEIRA P., SOARES D., LEITE S., SALLES E., WAISMAN M. Effects of thyroxine replacement on endothelial function and carotid artery intima-media thickness in female patients with mild subclinical hypothyroidism. Clinics. 2011; 66 (8):1321-8.Search in Google Scholar

11. AHIRWAR AK., JAIN A., SINGH A., GOSWAMI B., BHATNAGAR MK., BHATACHARJEE J. The study of markers of endothelial dysfunction in metabolic syndrome. Horm Mol Biol Clin Invest. 2015; 24 (3):131-6.Search in Google Scholar

12. BALZAN S., DEL CARRATORE R., NICOLINI G., BEFFY P., LUBRANO V., FORINI F et al. Proangiogenic effect of TSH in human microvascular endothelial cells through its membrane receptor. The Journal of Clinical Endocrinology & Metabolism. 2012 Mar 14; 97 (5):1763-70.10.1210/jc.2011-214622419707Search in Google Scholar

13. MEHRAN L., AMOUZEGAR A., RAHIMABAD PK., TOHIDI M., TAHMASEBINEJAD Z., AZIZI F. Thyroid Function and Metabolic Syndrome: A Population-Based Thyroid Study. Hormone and Metabolic Research. 2017 Mar; 49 (03):192-200.10.1055/s-0042-11727928351085Search in Google Scholar

14. TIAN L., ZHANG L., LIU J., GUO T., GAO C., NI J. Effects of TSH on the function of human umbilical vein endothelial cells. Journal of molecular endocrinology. 2014 Apr 1; 52 (2):215-22.10.1530/JME-13-011924444496Search in Google Scholar

15. TÜREMEN EE., ÇETINARSLAN B., SAHIN T., CANTÜRK Z., TARKUN I. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocrine journal. 2011; 58 (5):349-54.10.1507/endocrj.K10E-33321490407Open DOISearch in Google Scholar

16. DARDANO A., GHIADONI L., PLANTINGA Y., CARACCIO N., BEMI A., DURANTI E et al. Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. The Journal of Clinical Endocrinology & Metabolism. 2006 Oct; 91 (10):4175-8.10.1210/jc.2006-044016868055Search in Google Scholar

17. ITO A., TSAO PS., ADIMOOLAM S., KIMOTO M., OGAWA T., COOKE JP. Novel mechanism for endothelial dysfunction. Circulation. 1999 Jun 22; 99 (24):3092-5.10.1161/01.CIR.99.24.3092Search in Google Scholar

18. NOFER JR., VAN DER GIET M., TÖLLE M., WOLINSKA I., VON WNUCK LIPINSKI K., BABA HA. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P 3. The Journal of clinical investigation. 2004 Feb 15; 113 (4):569-81.10.1172/JCI200418004Search in Google Scholar